Thousands to benefit from spinal arthritis medication listing on PBS

The Morrison Government will make a medication for severe inflammatory spinal arthritis more affordable when it is listed on the Pharmaceutical Benefits Scheme (PBS), saving patients more than $15,000 a year. Almost 4,000 patients who suffer from active non-radiographic axial spondyloarthritis will benefit when Simponi® (Golimumab) becomes available on the PBS on December 1. Patients…

Details